Target Discovery, Inc. Company Profile

13:17 EDT 20th March 2018 | BioPortfolio

Target Discovery discovers, validates, and utilizes protein isoforms to improve clinical diagnosis and management of disease. A growing body of scientific literature shows that protein isoforms correlate more precisely with disease state and patient-specific treatment response than current clinical biomarkers. Most protein isoforms (90%) are made by the body after the protein is produced (post-translational modifications). Such protein modifications remain largely inaccessible to current immunodiagnostic and nucleic acid clinical assays. Target Discovery's Isonostic™ products are designed to make this isoform biomarker information accessible to clinicians.


4030 Fabian Way
Palo Alto
United States of America


Phone: 1.650.812.8100
Fax: 1.650.812.8130

News Articles [622 Associated News Articles listed on BioPortfolio]

A matter of mobility: New strategy for drug discovery

A joint industry/academia study of a cancer target protein reveals unusual relation between binding site flexibility and drug-target lifetime. The results suggest a new strategy for drug discovery.

CHI’s Discovery on Target, Sheraton Boston, Sept. 25-28, 2018

CHI’s Discovery on Target, Sheraton Boston, Sept. 25-28, 2018 Reporter: Aviva Lev-Ari, PhD, RN   ANNOUNCEMENT Leaders in Pharmaceutical Business Intelligence (LPBI) Group is a selected CHI ...

Bayer and PeptiDream enter into multi-target discovery collaboration

In a discovery and license collaboration valued up to $1.1bn, Japanese pharma PeptiDream Inc. will use its Peptide Discovery Platform System (PDPS) technology to identify macrocyclic/constrained pepti...

Deadly Parasite Could be Stopped by Scottish Researchers’ Discovery

A study in Scotland has improved our understanding of how a dangerous parasite functions, creating a new target for combatting deadly infections. Research from the University of Edinburgh has identi...

InterMed Discovery: The World's Largest Natural Product Library

In this interview Fintan Walton talks to Mr Erik Metz, Head of Business Development at InterMed Discovery - a Natural Product lead discovery company from Dortmund, Germany. Erik Metz explains how Inte...

Incyte and Syros Enter Global Target Discovery and Validation Collaboration Focused on Myeloproliferative Neoplasms

WILMINGTON, Del. & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Incyte Corporation (NASDAQ:INCY) and Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) announced today that the companies have entered into ...

Bristol-Myers Squibb Extends Partnership with Target PharmaSolutions for TARGET-NASH

CHAPEL HILL, N.C, Oct. 12, 2017 /PRNewswire/ — TARGET PharmaSolutions, Inc., a real-world clinical data company, is pleased to announce that Bristol-Myers Squibb (BMY) has extended its strategic...

Merck KGaA, Cancer Research UK, ICR Launch Three Drug Discovery Projects

Cancer Research UK and the Institute of Cancer Research, London (ICR), said they will partner with Merck KGaA on three research projects focused on cancer drug discovery, expanding on several earlier ...

PubMed Articles [1407 Associated PubMed Articles listed on BioPortfolio]

Early Probe and Drug Discovery in Academia: A Minireview.

Drug discovery encompasses processes ranging from target selection and validation to the selection of a development candidate. While comprehensive drug discovery work flows are implemented predominant...

Emerging Opportunities for Target Discovery in Rare Cancers.

Rare cancers pose unique challenges to research due to their low incidence. Barriers include a scarcity of tissue and experimental models to enable basic research and insufficient patient accrual for ...

Target class drug discovery.

Structural Coverage of the Proteome for Pharmaceutical Applications.

Structure-based computational drug discovery efforts have traditionally focused on the structure of a single, well-known drug target. Important applications, such as target deconvolution and the analy...

Pathway-based technologies for early drug discovery.

Although the traditional drug discovery approach has led to the development of many successful drugs, the attrition rates remain high. Recent advances in systems-oriented approaches (systems-biology a...

Clinical Trials [1666 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Efficacy and Safety of Imatinib in Scleroderma

In vitro studies have shown that imatinib 1mM inhibits strongly the growth of cutaneous fibroblasts. The hypothesis is that imatinib inhibits PDGFR which is known to be a potential target ...

Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain

VVZ-149 is a novel analgesic drug candidate that shows a potential analgesic activity inhibiting GlyT2 and 5HT2A simultaneously. These target receptors have been known to play important ro...

Road to Discovery for Combination Probiotic BB-12 With LGG in Treating Autism Spectrum Disorder

This study will evaluate the safety and tolerability of BB-12 with LGG in healthy children with autism spectrum disorder aged 6-13 years. Subjects will be randomized to BB-12 with LGG oral...

Companies [1606 Associated Companies listed on BioPortfolio]

Chemocept, Inc.

Chemocept is a service company offering the biotechnology industry discovery chemistry support capabilities for use in biomolecular target validation and small molecule drug discovery. We facilitate ...

Target Discovery, Inc.

Target Discovery discovers, validates, and utilizes protein isoforms to improve clinical diagnosis and management of disease. A growing body of scientific literature shows that protein isoforms correl...

Crystax Pharmaceuticals S.L.

Crystax Pharmaceuticals is a leading structure-based drug discovery company providing a unique service to its partners. Crystax has developed an integrated discovery platform, from the identification ...

Target ALS Foundation

Target ALS is an independent, non-profit, and privately funded consortium of researchers from academic and biotech/pharma laboratories entirely focused on finding a treatment for ...

Vividion Therapeutics, Inc.

Conventional drug discovery is target-centric; a compound library is screened using a target-specific assay and high-affinity binding ligands are optimized to develop a drug candi...

More Information about "Target Discovery, Inc." on BioPortfolio

We have published hundreds of Target Discovery, Inc. news stories on BioPortfolio along with dozens of Target Discovery, Inc. Clinical Trials and PubMed Articles about Target Discovery, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Target Discovery, Inc. Companies in our database. You can also find out about relevant Target Discovery, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Corporate Database Quicklinks

Searches Linking to this Company Record